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The 5* nontranslated RNA (5*NTR) of a genotype 1b hepatitis C virus (HCV-N) directs cap-independent
translation of the HCV-N polyprotein with about twofold less efficiency than the 5*NTR of a genotype 1a virus
under physiologic conditions (Hutchinson strain, or HCV-H) (M. Honda et al., Virology 222:31–42, 1996). Here,
we show by mutational analysis that substitution of the AG dinucleotide sequence at nucleotides (nt) 34 and
35 of HCV-N with GA (present in HCV-H) restores the translational activity to that of the HCV-H 5*NTR both
in vitro and in vivo. These nucleotides are located upstream of the minimal essential internal ribosome entry
site (IRES), as a 6-nt deletion spanning nt 32 to 37 also increased the translational activity of the HCV-N 5*NTR
to that of HCV-H. Thus, the upstream AG dinucleotide sequence has an inhibitory effect on IRES-directed trans-
lation. Surprisingly, however, this inhibitory effect was observed only when the translated, downstream RNA
sequence contained nt 408 to 929 of HCV (capsid-coding RNA). Further analysis of RNA transcripts containing
frameshift mutations demonstrated that the nucleotide sequence of the transcript, and not the amino acid
sequence of the expressed capsid protein, determines this difference in translation efficiency. The difference be-
tween the translational activities of the HCV-N and HCV-H transcripts was increased when translation was car-
ried out in reticulocyte lysates containing high K1 concentrations, with a sevenfold difference evident at 130 to 150
mM K1. These results suggest that there is an RNA-RNA interaction involving 5*NTR and capsid-coding sequences
flanking the IRES and that this is responsible for the reduced IRES activity of the genotype 1b virus, HCV-N.
Hepatitis C virus (HCV) is a positive-stranded, enveloped
RNA virus which is classified within the Hepacivirus genus of
the family Flaviviridae (3). This virus establishes persistent
infection in most infected humans, leading to the development
of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (1,
14). There is extensive genetic heterogeneity among different
HCV strains, with at least six major genotypes and a series of
related subtypes recognized thus far (5, 24). Among these,
genotype 1 is predominant worldwide and comprised of two
major subtypes, genotypes 1a and 1b (5). Although some clin-
ical studies have found no differences in the clinical expression
of liver disease related to the genotype of the infecting virus
(15), others have suggested that genotype 1b infections may be
more resistant to interferon therapy (17, 30) and may confer
greater risk for development of hepatocellular carcinoma than
infection with non-genotype 1b strains including genotype 1a
viruses (23).
Despite the considerable genetic diversity that exists among
different HCV strains, the 59 nontranslated RNA (59NTR) se-
quences of these viruses are relatively invariant. In large part,
this reflects the presence of conserved, highly ordered RNA
structures within the viral internal ribosome entry site (IRES)
which are required for the internal entry of ribosomes on the
viral RNA and subsequent cap-independent initiation of trans-
lation of the viral polyprotein (8, 12, 19–21, 27, 29). The RNA
segment which comprises the IRES occupies most of the
59NTR, as the 59 limit of the IRES has been mapped to be-
tween nucleotides (nt) 29 and 46 (11, 12). While the 39 bound-
ary of the IRES is less certain, several recent studies indicate
that the activity of the HCV IRES is dependent on sequence
located immediately downstream of the initiator AUG (12, 16,
19). The initiator AUG appears to be located within the single-
stranded segment of a stem-loop (stem-loop IV) which is
formed in part by the capsid protein-coding sequence at the
extreme 59 end of the large open reading frame of HCV (10)
(Fig. 1). Mutations which enhanced the stability of this putative
stem-loop significantly reduced the efficiency of internal initi-
ation of translation, suggesting that the stem-loop may play a
role in controlling translation of the viral polyprotein (10).
Larger RNA structures that are upstream of stem-loop IV are
absolutely essential for translational activity (12, 21, 28), but
the most 59 stem-loop within the 59NTR (stem-loop I, nt 5 to
20) appears to have an opposing action, as its deletion en-
hances the activity of the downstream IRES both in vitro and
in vivo (12, 21).
We noted previously that the 59NTR of a genotype 1a virus
(Hutchinson strain, or HCV-H) directed translation with great-
er efficiency than that of a genotype 1b virus (HCV-N) when
placed in the context of nearly genome-length viral RNA (12).
We found the IRES of the genotype 1a virus to be about
twofold more active than the IRES of the genotype 1b virus,
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both in a cell-free translation system and in transfected Huh-
T7 cells in vivo (12). Although it is not certain that a twofold
difference in translational efficiency would have a significant
impact on either virus replication or disease expression, we
considered it likely that the identification of the molecular
basis for this difference in activity could contribute to a better
understanding of the HCV IRES and the structure of the
59NTR. This would be important, because the IRES is increas-
ingly recognized as a potential target for antiviral drug devel-
opment. The sequences of the HCV-H and HCV-N 59NTRs
differ at only seven base positions, located at four separate sites
(Fig. 1). Significantly, none of the involved nucleotides are in-
volved in base pairing within recognized secondary or tertiary
RNA structures (2, 10).
MATERIALS AND METHODS
Plasmids. Plasmids pMN2-1G and PMN2/H have been described previously
(12). Plasmid pN-CDE1 contains cDNA representing nt 1 to 1357 (59NTR,
capsid-coding, and 59 E1-coding sequences) of the HCV-N virus (9) (genotype
1b) genome under the transcriptional control of the T7 promoter. It was con-
structed by subcloning the XmnI-BamHI fragment of pMN2-1G into pBluescript
IISK (Stratagene). pH-CDE1 is a similar plasmid which contains the 59NTR of
the HCV-H genotype (1a) fused to the 59 open reading frame of HCV-N. It was
FIG. 1. Proposed secondary and tertiary RNA structures within the 59NTR and the immediately downstream segment of the long open reading frame of the
genotype 1b virus HCV-N (10, 11). Major structural domains are labeled I, II, IIIa, IIIb, etc.; the initiator AUG codon in stem-loop IV is highlighted. The circled
nucleotides indicate differences between the sequences of HCV-N and the genotype 1a HCV-H virus, which are clustered at four loci: UGA, GA, A1, and A2.
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constructed by subcloning the XhoI-NheI fragment (containing the T7 promoter
sequence and nt 1 to 249 of the 59NTR) from pMN2/H into pN-CDE1. pN-CLuc
contains the 59NTR sequences of HCV-N and the first 66 nt of the HCV open
reading frame fused in frame to the firefly luciferase sequence, under control of
the T7 promoter. It was constructed by inserting a PCR-amplified fragment of
pGEM-Luc (Promega) into the AatII and BamHI sites of pN-CDE1. pH-CLuc
was constructed subsequently by inserting the luciferase sequence from pN-CLuc
into the AatII and BamHI sites of pH-CDE1. pN-CAT and pH-CAT contain the
59NTR sequences of HCV-N and HCV-H, respectively, with 8 nt of the open
reading frame fused in frame to the bacterial chloramphenicol acetyltransferase
(CAT) sequence under T7 promoter control. These were constructed by insert-
ing the small NheI-BamHI fragment of pWT-CAT (21) into pN-CDE1 or pH-
CDE1.
The bicistronic construct pCAT-N(A2)-CLuc contains a T7 transcriptional
unit in which the CAT sequence is fused at its 39 end to the 59NTR of HCV-N
(with a change of G to A at nt 243) and 66 nt of the HCV open reading frame
fused in frame with the luciferase sequence. It was constructed by inserting the
NheI-XmnI fragment of pN-CLuc into pKCUS2 (gift from B. Clarke, Glaxo-
Wellcome). pCAT-N-CLuc and pCAT-H-CLuc are similar constructs containing
the 59NTR sequences of HCV-N and HCV-H, respectively. pCAT-N-CDE1 is
another bicistronic plasmid in which the naturally fused HCV capsid and 59
E1-coding sequences represent the second cistron. It was constructed by insert-
ing the NheI-BamHI fragment of pN-CDE1 into pCAT-N-CLuc. The nearly ge-
nome-length bicistronic constructs pCAT/N, pCAT/H, pCAT/N(UGA), pCAT/N
(GA), pCAT/N(A1), and pCAT/N(A2) were constructed by ligating XmnI-
BamHI fragments excised from mutated subgenomic bicistronic plasmids with
the large BamHI-XmnI fragment of pMN2-1G (HCV nt 1358 to 9454). pN-CDE1
(H) and pH-CDE1(H) are monocistronic constructs that contain the 59NTR of
HCV-N and HCV-H, respectively, fused naturally to the HCV-H open reading
frame as the second cistron. These were created by inserting the NheI-BamHI
fragment of pRC/CMV/HCV-H (gift from H. Lerat) into pN-CDE1 and pH-
CDE1, respectively.
pCAT-N-CDE1(Fs) and pCAT-H-CDE1(Fs) contain frameshift mutations in
the capsid-coding region. These were constructed by amplifying the capsid region
with the 59 primer, 59-ATAGAATTCGACGTCAGTTCCCGGGCGG-39, which
lacks A-409 and the 39 primer, 59-TATAGATCTCCTAGGGGGGCCGCCGA
CGAGCGGA-39, which inserts a cytosine at nt 769, thus restoring the original
reading frame and maintaining its patency. The amplified PCR fragment was in-
serted into EcoRI and BglII sites of pSP73 (Promega). The resultant plasmid was
digested with AatII and AvrII, and the small fragment was cloned into pCAT-N-
CDE1 and pCAT-H-CDE1 to make pCAT-N-CDE1(Fs) and pCAT-H-CDE1
(Fs), respectively.
Site-directed mutagenesis of these plasmids (see Results) was carried out by
using a standard PCR-based strategy, with Pfu (Pyrococcus furiosus) DNA poly-
merase. Reactions were for 35 cycles of 95°C for 1 min, 42°C for 1.5 min, and
75°C for 3 min. The sequences of the PCR-manipulated regions and the presence
of expected mutations were confirmed by DNA sequencing. Plasmid DNAs were
purified on Qiagen-tip 500 columns (Qiagen, Chatsworth, Calif.).
Cells. Huh-T7 cells (22), which are derived from Huh-7 human hepatocellular
carcinoma cells, are stably transformed and constitutively express bacteriophage
T7 RNA polymerase. Cell cultures were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum, penicillin, strepto-
mycin, and 400 mg (active compound) of geneticin (Gibco/BRL) per ml.
Antibodies. Murine monoclonal antibody to the HCV capsid protein, 27D5G5,
was generously provided by Michel Jolivet, BioMerieux. Rabbit polyclonal anti-
body against CAT was purchased from 59339, Inc. (Boulder, Colo.).
In vitro transcription and translation reactions. Plasmids were linearized by
digestion with BamHI or MluI (pN-CDE1, pN-CLuc, pN-CAT, pCAT-N-CDE1,
pCAT-N-CLuc, and related mutants) or XhoI (pCAT/N and related mutants).
RNA was transcribed by T7 RNA polymerase, using Riboprobe System II (Pro-
mega) or Megascript (Ambion) reagents as recommended by the manufacturer.
Transcription products were treated with RQ1 DNase (Promega) for 15 min at
37°C, extracted with phenol-chloroform, precipitated with ethanol–7.5 M ammo-
nium acetate, and examined by agarose gel electrophoresis. The concentration of
RNA was estimated by spectrophotometry. In some experiments, RNA was sep-
arated from nonincorporated nucleotides by chromatography through a Seph-
adex G-25 column and quantified by gel analysis. In vitro translation was carried
out in micrococcal nuclease-treated rabbit reticulocyte lysate, with or without
canine pancreatic microsomal membranes (Promega). The effects of varied KCl
concentration were determined by using the Flexilysate system (Promega). Un-
less otherwise specified, translation reactions (25 ml) were programmed with 0.5
to 2.0 mg of RNA and incubated at 30°C for 1 h. Total translation products were
separated by 12 or 13% sodium dodecyl sulfate (SDS)-polyacrylamide—6 M urea
gel electrophoresis (PAGE) followed by autoradiography. Translation products
were quantified by PhosphorImager (Molecular Dynamics, Inc.) analysis.
Stability of HCV-H and HCV-N RNAs in reticulocyte lysate. Synthetic RNA
transcripts of pN-CDE1 and pH-CDE1 were trace labeled with 32P (2.4 3 105
cpm/mg of RNA) and used to program reticulocyte lysate for in vitro translation
as described above (1 mg of RNA per 25 ml of reaction mixture); 3-ml aliquots of
the reaction mixture were sampled at 0, 20, 40, and 60 min and analyzed by elec-
trophoresis in a 2% agarose–0.1% SDS gel. The gel was dried and then subjected
to autoradiography and PhosphorImager analysis.
Vaccinia virus-T7 hybrid expression of bicistronic RNA transcripts in trans-
fected Huh-T7 cells. Huh-T7 cells were seeded into four-well tissue culture cham-
ber slides 24 h prior to transfection. Cells (90% confluent) were infected with re-
combinant vaccinia virus vTF7-3 (expressing T7 RNA polymerase) (7) in 100 ml
of Opti-MEM (Gibco/BRL) at a multiplicity of infection of 10. Following a 1-h
incubation at 37°C, the virus inoculum was removed and replaced with a mixture
containing 1 mg of bicistronic plasmid DNA [pCAT/N, pCAT/H, pCAT/N
(UGA), pCAT/N(GA), pCAT/N(A1), or pCAT/N(A2)] and 3 ml of Lipofectin
(Gibco/BRL) in 40 ml of Opti-MEM at 37°C, followed 15 min later by an addi-
tional 200 ml of Opti-MEM (12). Cells were subsequently incubated at 37°C in a
5% CO2 atmosphere for 24 h.
Fluorescence image cytometry. Transfected Huh-T7 cells were washed with
phosphate-buffered saline fixed in acetone-methanol (1:1), and stained with rab-
bit antibody to CAT (1:50 final dilution; 59339, Inc.) and murine monoclonal
antibody to the HCV capsid protein (27D5G5; 1:12,000 dilution; generous gift
from Michel Jolivet). After a further wash, the cells were incubated with a mix-
ture of fluorescein isothiocyanate (FITC)-conjugated swine antibody to rabbit
immunoglobulin (DAKO) and tetramethyl rhodamine isothiocyanate (TRITC)-
conjugated goat antibody to mouse immunoglobulin (Organon-Teknika-Cappel,
Durham, N.C.), each diluted 1:40. The stained cells were washed extensively in
phosphate-buffered saline and examined at a magnification of 340 with a Micro-
phot FXA epifluorescence microscope (Nikon), using filter sets for TRITC or
FITC fluorescence. Fluorescence images were recorded with a charge-coupled
device camera (Optronics Engineering) and NIH Image acquisition software.
Duplicate FITC- and TRITC-labeled images from 30 dually stained cells from
each transfected culture were transferred to a DEC 5000/200 workstation (Digi-
tal Equipment Corporation), and the boundaries of positive cells were automat-
ically extracted by using IGLOO (Image Graphics Library Object-Oriented) (4)
and newly developed algorithms allowing automatic generation of cell masks
(13). The contribution of nonspecific labeling to the image was eliminated by
subtracting the average grey scale intensity of the background image from the
integrated intensity. The ratio of the integrated intensities of the TRITC- and
FITC-labeled images was subsequently calculated for each cell.
RESULTS
Relative efficiency of translation directed by genotype 1a
(HCV-H) and genotype 1b (HCV-N) 5*NTRs in vitro. To better
quantify the difference in translational activities of the IRESs
of HCV-N and HCV-H, we examined the abilities of RNAs
transcribed in vitro from plasmids pN-CDE1 and pH-CDE1 to
direct translation of HCV proteins in rabbit reticulocyte ly-
sates. These transcripts represented the 59NTR sequences of
HCV-N and HCV-H, respectively, fused naturally to nt 342 to
1357 of the open reading frame of HCV-N. The in vitro trans-
lation reactions (25 ml each) were programmed with 0.25 to
2 mg of RNA (10 to 80 mg/ml) and supplemented with micro-
somal membranes to allow signalase cleavage at the capsid-E1
junction. The major products of translation included the
21-kDa capsid protein, a 30-kDa truncated, glycosylated E1
protein (DE1), and a 34-kDa unprocessed precursor protein
(C-DE1) (Fig. 2A). Lesser quantities of two higher-molecu-
lar-mass proteins (46 and 54 kDa) were also observed in some
experiments. Although no efforts were made to specifically
identify these proteins, they likely represent aggregates of the
major products. At each RNA concentration, greater quanti-
ties of all of these proteins were produced by the HCV-H
transcripts. PhosphorImager (Molecular Dynamics) analysis
indicated that the quantities of the capsid and DE1 proteins
increased in a linear fashion over the range of the RNA con-
centrations used to program translation (Fig. 2B). On average,
pH-CDE1 transcripts produced 2.4-fold more capsid protein
and 1.8-fold more DE1 compared with pN-CDE1 transcripts.
To exclude the possibility that the difference in the amounts
of capsid and DE1 proteins produced by the pN-CDE1 and
pH-CDE1 transcripts could be due to differences in stability of
these RNAs, we programmed reticulocyte lysate with trace-
labeled RNA transcripts. Reactions were sampled at 20, 40,
and 60 min, and the integrity of the RNA was determined by
gel electrophoresis. Approximately 60% of each RNA tem-
plate was degraded during the first 20 min of the reaction (data
not shown), but there were no differences in the rates of deg-
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radation of the pN-CDE1 and pH-CDE1 RNAs. These results
were confirmed by RNase protection assays using an RNA
probe targeted to the capsid-coding region, which also showed
no differences in the rate of disappearance of the protected
RNA fragment following addition of pN-CDE1 and pH-CDE1
transcripts to reticulocyte lysate (data not shown). Taken to-
gether, these results confirm that the 59NTR of HCV-H is
about twice as active as that of HCV-N in directing translation
of the HCV polyprotein in rabbit reticulocyte lysates.
Genetic basis of the difference in translational activities of
HCV-H and HCV-N. As indicated above, the 59NTR sequences
of the these two viruses differ at seven nucleotide positions
(Fig. 1). To determine which of these differences in the nu-
cleotide sequences of these RNAs were responsible for the
variation in translational activity, we constructed a series of
chimeric 59NTR constructs in which the four nucleotide sub-
stitution groups present in the HCV-H sequence (Fig. 1) were
systematically introduced into the background of the HCV-N
sequence in pN-CDE1 (Fig. 3A). Plasmids pN-UGA, pN-GA,
pN-A1, and pN-A2 contain the HCV-H substitutions at nt 11 to
13 (GAU3UGA), 34 and 35 (AG3GA), 204 (C3A), and 243
(G3A), respectively. RNAs transcribed from these plasmids
in vitro were used to program reticulocyte lysates for transla-
tion at a concentration of 40 mg/ml (Fig. 3B). The amounts of
capsid and DE1 proteins produced from pN-GA transcripts
(Fig. 3B, lane 4) were nearly equivalent to those produced by
pH-CDE1 transcripts (lane 2), while pN-UGA, pN-A1, and
pN-A2 transcripts (lanes 3, 5, and 6) had translational activities
approximating that of RNA transcribed from pN-CDE1 (lane
1). These differences were reproducible in three separate
experiments and were confirmed by PhosphorImager anal-
ysis (Fig. 3C).
We also studied chimeric transcripts which contained com-
binations of two nucleotide substitution groups: pN-UGA z
GA, pN-UGA z A1, pN-UGA z A2, pN-GA z A1, pN-GA z A2,
and pN-A1 z A2 (Fig. 3A). RNA transcripts derived from pN-
UGA z GA, pN-GA z A1, and pN-GA z A2 (Fig. 3B, lanes 10,
13, and 14), which all contain the GA substitution at nt 34 and
35, were translated with an efficiency equivalent to that for pH-
CDE1 (Fig. 3B, lane 9). In contrast, translation of the re-
maining chimeric transcripts, which contain AG at this locus
(pN-UGA z A1, pN-UGA z A2, and pN-A1 z A2; lanes 11, 12,
and 15), did not exceed that of pN-CDE1 RNA (lane 8). These
findings were reproducible and confirmed by PhosphorImager
analysis (Fig. 3C). They strongly support the conclusion that
the AG3GA substitution at nt 34 and 35 is responsible for the
increased translational activity of the HCV-H 59NTR.
Base substitutions at nt 34 and 35 influence the efficiency of
translation only on transcripts containing the complete cap-
sid-coding region. In an effort to develop a sensitive reporter
assay to test the effects of these nucleotide substitutions on
IRES activity in vivo (see below), we constructed plasmids
(pN-CLuc and pH-CLuc) in which sequence encoding the re-
porter protein, firefly luciferase, was fused in frame at nt 408 of
the HCV sequence in pN-CDE1 and pH-CDE1, thus replacing
the sequence downstream of nt 66 of the HCV open reading
frame. We also constructed dicistronic variants of these plas-
mids (pCAT-N-CLuc and pCAT-H-CLuc), in which sequence
encoding bacterial CAT was placed upstream of the HCV
59NTR. Synthetic RNA transcripts derived from these plas-
mids were used to program reticulocyte lysates for translation.
Surprisingly, we found that the type of 59NTR sequence
(HCV-H or HCV-N) had no influence on the translational
efficiency of either the monocistronic (Fig. 4A, lane 1 versus
lane 2) or dicistronic (lane 3 versus lane 4) transcripts. The
absence of a significant difference in the translational activities
of the monocistronic transcripts (pN-CLuc and pH-CLuc) was
confirmed by direct assay of the translation products for lucif-
erase activity (data not shown), while the absence of a differ-
ence between the dicistronic transcripts (pCAT-N-CLuc and
pCAT-H-CLuc) was confirmed by PhosphorImager analysis of
the relative quantities of luciferase and CAT produced in each
reaction (Fig. 4B). Similarly, we found no differences in the
translational activities of dicistronic RNA transcripts which
contained the HCV-H base substitutions within the back-
ground of the HCV-N 59NTR [pCAT-N(UGA)-CLuc, pCAT-
N(GA)-CLuc, pCAT-N(A1)-CLuc, and pCAT-N(A2)-CLuc]
(data not shown).
To determine whether the absence of a translational differ-
ence could be due specifically to the presence of the luciferase
sequence, we assessed the translational activity of monocis-
tronic transcripts derived from pN-CAT and pH-CAT (21).
These constructs contain the CAT reporter protein sequence
fused in frame to HCV capsid-coding sequence but preserve
only 8 nt of the original HCV open reading frame. As with the
luciferase reporter transcripts, there were no differences in the
amount of CAT produced from these RNAs in rabbit reticu-
locyte lysates (data not shown).
In contrast to these results, dicistronic transcripts in which
the truncated HCV open reading frame (CDE1) represented
the downstream cistron (pCAT-N-CDE1 and pCAT-H-CDE1)
retained the increased translational activity observed with the
HCV-H 59NTR in earlier analyses of monocistronic transcripts
(Fig. 4A, lane 5 versus lane 6; Fig. 4B). The greater transla-
tional activity of the HCV-H 59NTR was evident whether these
FIG. 2. Translation of RNA transcripts containing genotype 1a HCV-H or
genotype 1b HCV-N 59NTR sequences. (A) SDS-PAGE of products of transla-
tion from rabbit reticulocyte lysates programmed with 2 (lanes 1 and 2), 1 (lanes
3 and 4), 0.5 (lanes 5 and 6), 0.25 (lanes 6 and 8), or 0 (lane 9) mg of RNA derived
from pH-CDE1 (containing the 59NTR of HCV-H; lanes 1, 3, 5, and 7) or
pN-CDE1 (containing the 59NTR of HCV-N; lanes 2, 4, 6, and 8) per 25-ml
reaction. (B) Quantitative analysis (relative PhosphorImager band volume) of
HCV capsid (left) and DE1 (right) proteins produced in reticulocyte lysates
programmed with increasing concentrations of RNA transcribed from pH-CDE1
(■) or pN-CDE1 (h).
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FIG. 3. Genetic basis for the difference in translational activities of the HCV-N and HCV-H 59NTRs. (A) Organization of T7 transcriptional units within chimeric
constructs containing the unique nucleotide sequences of HCV-H placed individually and in combination within the background of the HCV-N 59NTR and immediately
downstream segment of the open reading frame encoding C-DE1 (pN-CDE1). Protein-coding regions are shown as rectangles; noncoding RNA is shown as a solid line.
Map positions of the base substitutions are shown at the bottom. (B) SDS-PAGE of products of translation from reticulocyte lysates programmed with RNAs
transcribed from the plasmids depicted in panel A. The two panels represent results from separate experiments. The gel positions of the capsid (C), DE1, and
nonprocessed C-DE1 protein products are shown at the right. (C) PhosphorImager analysis of capsid protein quantities produced in translation experiments such as
those shown in panel B. The measured band volumes were normalized to that of reactions programmed with RNA from pN-CDE1 (51.0). The error bars represent
the standard error calculated from the results of three separate experiments.
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reaction mixes were supplemented or not supplemented with
microsomal membranes (data not shown). Although the base
substitutions at nt 34 and 35 of the HCV-H 59NTR are respon-
sible for its greater translational activity (Fig. 3), these results
indicate that the difference in translational activity that these
substitutions confer is evident only when the transcript con-
tains natural HCV sequences downstream of nt 408.
To further define the downstream sequence required for
the enhanced translational activity of the HCV-H 59NTR,
we compared nearly genome-length dicistronic RNA transcripts
containing the HCV-H or HCV-N 59NTR fused naturally to
HCV-N sequence extending to nt 9454 of the HCV genome
(plasmids pCAT/N and pCAT/H) (12). While these RNAs pro-
duced equivalent amounts of CAT in reticulocyte lysates, Phos-
phorImager analyses indicated that 1.8-fold more capsid pro-
tein was produced from pCAT/H than from pCAT/N (data not
shown). Thus, the inclusion of HCV sequence beyond the trun-
cated CDE1 segment did not influence the relative transla-
tional activities of the HCV-H and HCV-N 59NTRs. We next
examined the translational activities of dicistronic transcripts
which contained only the capsid-coding sequence within the
downstream cistron. These RNAs were prepared by runoff
transcription of MluI-digested pCAT-N-CDE1 and pCAT-H-
CDE1 plasmid DNAs; they terminated at nt 929 of the HCV
genome. We again noted significantly greater production of
capsid protein by transcripts containing the HCV-H 59NTR
(data not shown). Thus, we conclude that the capsid-coding
sequence between nt 408 and 929 is required for expression
of the difference between the translational activities of the
HCV-N and HCV-H 59NTRs.
Expression of the capsid protein is not required for the en-
hanced translational activity of HCV-H. Experiments with chi-
meric polioviruses in which the native picornavirus IRES was
replaced by the IRES of HCV suggested that the HCV capsid
FIG. 4. (A) SDS-PAGE of products of translation from reticulocyte lysates
programmed with monocistronic (lanes 1 and 2) or dicistronic (lanes 3 and 4)
RNAs in which the HCV capsid sequence beyond nt 66 of the open reading
frame was replaced with luciferase sequence. The major luciferase product ap-
pears as a band of ;67 kDa, while CAT migrates with an apparent molecular
mass of ;24 kDa. Lanes 5 to 10 show a further analysis of the requirements for
downstream HCV coding sequence. In pCAT-N-CDE1(Fs) and pCAT-H-CDE1
(Fs) transcripts, the HCV capsid coding sequences contain 21 and 11 frameshift
mutations at nt 409 and 769, respectively, resulting in the expression of the C(Fs)
protein which contains nonsense sequence replacing much of the natural capsid
sequence. Nucleotides 32 to 37 are deleted from the HCV-N 59NTR sequence
within pCAT-N-CDE1(D32-37). The gel positions of the capsid (C), DE1, non-
processed C-DE1, luciferase (Luc), and CAT protein products are shown at the
right. The most rapidly migrating band observed in lanes 3 to 9 is an unidentified
product of the dicistronic RNAs that appears to be derived from the upstream
CAT reading frame by an uncertain initiation event. The quantity of this product
was closely tied to the quantity of CAT produced in these reactions, and it was not
considered in calculating the quantitative estimates of IRES activity shown in Fig.
4B. (B) PhosphorImager analysis of products of translation reactions programmed
with dicistronic RNAs in panel A. For each pair of reactions programmed with
RNAs containing the HCV-N or HCV-H 59NTRs, the ratio of the band volumes
of the capsid protein and CAT were normalized to the ratio obtained with RNA
containing the HCV-N 59NTR (pCAT-N-CLuc or pCAT-N-CDE1 5 1.0). Error
bars represent the standard error calculated from replicate experiments.
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protein might play a role in facilitating the internal initiation of
translation (16). If this hypothesis is correct, the fact that we
observed differences in the translational activities of the HCV-
H and HCV-N 59NTRs only when they were fused to the na-
tive HCV capsid sequence could be explained by differences in
the interaction of these 59NTRs with the capsid protein. Al-
ternatively, the requirement for capsid sequence could reflect
an interaction of this RNA with sequences within the 59NTR.
To distinguish between these two possibilities, we introduced
frameshift mutations into the capsid coding sequence of pCAT-
N-CDE1 and pCAT-H-CDE1. The resulting plasmids, pCAT-
N-CDE1(Fs) and pCAT-H-CDE1(Fs), each contain two muta-
tions: a 21 frameshift at nt 409 and a 11 frameshift at nt 769,
the latter of which restores the original reading frame and
maintains its patency to the end of the truncated E1 sequence.
Thus, although transcripts produced from these plasmids differ
by only 2 nt from the RNAs transcribed from pCAT-N-CDE1
and pCAT-H-CDE1, they encode a markedly altered capsid
protein, C(Fs), which consists of nonsense sequence between
residues 23 and 143, or for approximately 63% of its sequence.
As shown in Fig. 4A, both C(Fs) and unprocessed C(Fs)DE1
migrated more rapidly than the native capsid and unprocessed
CDE1 proteins in SDS-PAGE (compare lanes 7 and 8 with lanes
5 and 6). However, significantly greater quantities of these non-
sense proteins were expressed from pCAT-H-CDE1(Fs) com-
pared with pCAT-N-CDE1(Fs) transcripts (compare lanes 7
and 8). By PhosphorImager analysis, there was approximately
1.8-fold more C(Fs) produced from transcripts containing the
HCV-H 59NTR (Fig. 4B). Since previous experiments had
demonstrated that the difference in translational activity re-
quired the presence of sequence between nt 408 and 929, these
data strongly suggest that the difference in IRES activity is
dependent on the nucleotide sequence of the RNA and not the
amino acid sequence of the protein which it encodes.
The AG dinucleotide sequence at nt 34 and 35 of HCV-N has
an inhibitory effect on translation. The 59 limit of the minimal
essential HCV IRES sequence has not been precisely mapped.
However, several studies suggest that it is located downstream
of the dinucleotide sequence at nt 34 and 35, which we found
to be primarily responsible for the difference in the transla-
tional activities of HCV-H and HCV-N transcripts (Fig. 3)
(20). Since the nature of the sequence at nt 34 and 35 was
found to have such an important effect on the translational
activity of HCV transcripts, it was of interest to further inves-
tigate whether sequence in this region is required for the in-
ternal initiation of translation on these RNAs. Thus, we cre-
ated a 6-nt deletion mutation (nt 32 to 37) in pCAT-N-CDE1,
resulting in plasmid pCAT-N-CDE1(D32-37). Interestingly, di-
cistronic transcripts derived from this plasmid retained robust
IRES activity. The amount of capsid protein produced from
the pCAT-N-CDE1(D32-37) transcripts (Fig. 4A, lane 9) was
approximately 2.4-fold higher than the amount produced by
transcripts from pCAT-N-CDE1 (lane 5) and approximately
equivalent to the amount produced by transcripts containing
the HCV-H 59NTR (lane 6). These results indicate that the
AG dinucleotide sequence at nt 34 and 35 is inhibitory to
translation directed by the IRES in pCAT-N-CDE1. They were
confirmed by PhosphorImager analysis in replicate experi-
ments (Fig. 4B). Thus, the sequence at nt 34 and 35 is located
upstream of the 59 end of the minimal IRES, even though the
presence of an AG dinucleotide at this position has an inhib-
itory effect on the activity of the IRES within the genotype 1b
virus. Since we have recently shown that a substitution of the
sequence at nt 45 and 46 significantly reduces IRES activity
(11), these results map the 59 border of the IRES to the
segment between nt 38 and 46, or at the 59 end of stem-loop II
(Fig. 1).
The dinucleotide sequence at nt 34 and 35 determines the
efficiency of internal initiation of translation in vivo. Because
the studies described above were carried out in vitro with a
cell-free translation system, it was important to compare the
translational activities of the HCV-H and HCV-N 59NTRs in
vivo. For this purpose, we used the hybrid virus vTF7-3 (7) to
direct RNA transcription in Huh-T7 cells (22) transfected with
the nearly genome-length, bicistronic plasmids pCAT/H and
pCAT/N. CAT and capsid protein expression were measured
by quantitative, single-cell, double-label, indirect immunoflu-
orescence cytometry. This method allows the ratio of digitally
recorded, integrated intensities of the TRITC-labeled capsid
image and the FITC-labeled CAT image to be calculated for
individual transfected cells (see Materials and Methods for de-
tails). As the level of CAT reflects the abundance of the bicis-
tronic RNA transcripts within each cell, the ratio of capsid pro-
tein to CAT should be proportional to the strength of the
IRES in each transcript.
In these double-label experiments, approximately 30 to 40%
of the cells stained positively for both CAT and capsid proteins
(not shown) after transfection with the bicistronic plasmids.
Thirty of these cells were sampled from each transfected cul-
ture and subjected to quantitative analysis (Fig. 5). Although
there was considerable cell-to-cell variation in the capsid/CAT
(TRITC/FITC) ratio, on average this ratio was approximately
1.9-fold higher in cells transfected with pCAT/H than in those
transfected with pCAT/N (P , 0.01). Thus, these results are re-
markably concordant with the in vitro data and confirm that
the 59NTR of HCV-H has greater intrinsic activity than the
59NTR of HCV-N in vivo. We next analyzed cells transfected
with variants of pCAT/N which contained the individual groups of
base substitutions present in the 59NTR of HCV-H: pCAT/N
(UGA), pCAT/N(GA), pCAT/N(A1), and pCAT/N(A2) (Fig.
1). As pCAT/N(GA) was the only one of these plasmids to ex-
press the capsid protein at levels equivalent to that of pCAT/H
(1.74-fold-higher than pCAT/N; P , 0.01), these results con-
firmed that the dinucleotide sequence at nt 34 and 35 of HCV-
H is responsible for its increased translational activity in vivo.
The AG dinucleotide sequence and downstream coding re-
gion influence the optimal KCl concentrations for IRES-di-
rected translation in vitro. The results described above are
consistent with an interaction between RNA segments posi-
tioned upstream and downstream of the IRES that is detri-
mental to translation of the HCV-N sequence (see Discus-
sion). If this interaction were due to base pairing between the
flanking RNA segments, it should be enhanced at higher ionic
strengths, leading to a greater reduction in the translational
activity of the IRES. To test this hypothesis, we assessed the
translational activity of pN-CDE1 and pH-CDE1 transcripts in
the cell-free system at KCl concentrations ranging from 50 to
150 mM. These experiments demonstrated a striking difference
in the translational activities of the HCV-H and HCV-N
59NTRs at higher concentrations of KCl (Fig. 6A). pN-CDE1
transcripts were optimally translated at about 80 mM KCl, with
significantly reduced translation at higher KCl concentrations.
In contrast, the translation of pH-C-DE1 transcripts was re-
markably preserved at higher KCl concentrations, resulting in
a much increased difference in the relative translational activ-
ities of the two transcripts. At 150 mM KCl, translation of
pH-CDE1 was approximately sevenfold that of pN-CDE1 (Fig.
6A; compare lanes 9 and 10).
To determine whether the differing responses to increased
concentrations of KCl were due to the sequence differences
that we had found to be responsible for the increased transla-
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tional activity of HCV-H, we assessed the translational activity
of pN-GA transcripts at 80 and 150 mM KCl. Although pN-
GA differs from pN-CDE1 only by the GA-for-AG substitution
at nt 34 and 35, pN-GA transcripts behaved similarly to pH-
CDE1 transcripts, with relatively efficient translation even at
150 mM KCl (Fig. 6B; compare lanes 4 to 6). Thus, the marked
sensitivity of the HCV-N IRES to increasing concentrations of
KCl is related to the AG dinucleotide sequence at nt 34 and 35.
Similar experiments demonstrated that replacement of the
HCV-N open reading frame (downstream of nt 409) with the
luciferase-coding sequence in pN-CLuc also eliminated the
substantial suppression of HCV-N translation at higher KCl
concentrations (compare lanes 1 and 3 in Fig. 6C with lanes 1
and 4 in Fig. 6B). Thus, as in the experiments described above,
the reduced translation of the HCV-N transcripts at high con-
centrations of KCl is determined by a combination of se-
quences within RNA segments flanking the IRES. These data
are thus supportive of the hypothesis that there is an interac-
tion between these flanking RNA segments that is detrimental
to IRES-directed translation in HCV-N.
Finally, we determined whether a similar interaction might
exist between the HCV-H 59NTR and HCV-H polyprotein-
coding sequence. Monocistronic transcripts derived from pN-
CDE1 and pH-CDE1(H), or pN-CDE1(H) and pH-CDE1, con-
tain homologous (H-H and N-N for simplicity) or heterologous
(N-H and H-N) combinations of the 59NTRs and polyprotein-
coding sequences of HCV-H and HCV-N, respectively. These
were used to program reticulocyte lysates under a range of KCl
concentrations. At 80 mM KCl, the H-N chimeric sequence
translated with about 2.5-fold-greater activity than the N-N se-
quence (Fig. 7A), consistent with earlier observations. Although
the H-N chimera demonstrated an optimal KCl concentration
of about 80 mM, it remained reasonably well translated at 130
or even 150 mM KCl, relative to translation of the N-N chi-
mera. Strikingly, H-H transcripts were the most active trans-
lationally, with an optimal KCl concentration of 110 mM KCl,
and with translation at 130 mM that was equal to or exceeded
that at 80 mM KCl (Fig. 7B). These results were reproducible
in separate experiments. The results shown in Fig. 7 indicate
that either the 59NTR or the open reading frame of HCV-N
contributes to a lessening of translational activity when fused
to HCV-H sequence to form a chimera. In this context, the
suppressive effect of the 59NTR is greater than that of the
polyprotein-coding region.
DISCUSSION
The results described in this report have important implica-
tions for the structure of HCV RNA, although their relevance
to potential differences in the pathogenesis of infections with
genotypes 1a and 1b is much less certain, as discussed below.
First of all, it is important to note that the seven base
substitutions which distinguish the 59NTRs of the HCV-H and
HCV-N viruses are representative of differences in the se-
quences of other genotype 1a and 1b viruses. We compared the
complete 59NTR sequences of 25 different genotype 1a and 1b
viruses from GenBank (many other 59NTR sequences listed in
GenBank lack the extreme 59 end). The most frequent differ-
ences between the 1a and 1b strains were those which distin-
guish the HCV-H and HCV-N strains, at nt 11 to 13 (UGA
versus GAU in 1a and 1b, respectively), nt 34 and 35 (GA ver-
sus AG), nt 204 (A versus C), and nt 243 (A versus G). Im-
portantly, all 17 genotype 1b sequences contained the AG di-
nucleotide sequence at nt 34 and 35, while this sequence was
present in only 1 of 8 genotype 1a strains. Thus, the differences
that we have found in the translational activities of the HCV-H
and HCV-N 59NTRs likely typify differences between most
genotype 1a and 1b viruses.
FIG. 5. Quantitative, single-cell, indirect immunofluorescence cytometry for HCV capsid and CAT proteins, following infection of Huh-T7 cells with vTF7-3 and
transfection with plasmid DNAs containing nearly genome-length HCV sequences with the 59NTRs of HCV-N or HCV-H (N, pCAT/N; H, pCAT/H) (see text) or
pCAT/N derivatives containing the indicated nucleotide substitutions present in the HCV-H 59NTR (Fig. 1). Each point represents the ratio of capsid (TRITC label)
to CAT (FITC label) content for a single cell. Horizontal bars depict means 6 standard deviations (values shown below each data set). P values indicate significant
differences from values obtained in cells transfected with pCAT-N-CDE1.
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Although the reduced translational activity of the genotype
1b 59NTR was shown to be due to an inhibitory effect of the
AG dinucleotide sequence at nt 34 and 35 (Fig. 3 and 4), this
difference was expressed only when transcripts contained
the complete HCV capsid coding sequence (nt 1 to 929). Pre-
vious studies have suggested that sequence downstream of the
59NTR, within the most 59 30 nt of the open reading frame,
may influence the activity of the HCV IRES (10, 12, 19).
However, the region identified as influencing translational ac-
tivity in this study lies much further downstream. We found no
difference in the translational activities of transcripts contain-
ing the 1a and 1b 59NTRs and the first 66 nt of the HCV open
reading frame fused to the luciferase-coding sequence (Fig. 4).
Thus, the downstream nucleotide sequence required for ex-
pression of the difference between genotypes 1a and 1b in
translational activities resides between nt 408 and 929 of the
HCV genome. The primary nucleotide sequences of the geno-
type 1a and 1b viruses that we studied differ at approximately
12% of base positions within this segment. A further striking
observation was that deletion of nt 32 to 37, including the AG
dinucleotide sequence, from the HCV-N 59NTR did not im-
pair but actually enhanced translation from dicistronic tran-
scripts. Thus, both the upstream and downstream determinants
of the greater translational activity of the genotype 1a 59NTR
are located outside the minimal essential IRES sequence.
The fact that RNA sequences within the coding region as
well as upstream of the IRES act cooperatively to influence the
activity of the IRES suggests that these upstream and down-
stream RNA segments physically interact with each other in a
fashion that may influence the secondary or tertiary structure
of RNA within the IRES, or otherwise alters its availability to
interact with the 40S ribosome subunit (18). Alternatively, it is
possible that an interaction between upstream sequence at nt
34 and 35 and sequence within the capsid-coding region is
inhibitory to passage of ribosomes on the coding sequence,
thus leading to premature termination of translation or a slow-
er rate of translation. We did not observe any HCV-specific
products of translation with a molecular mass less than that of
the capsid protein among the products of the in vitro transla-
tion reactions, but very small polypeptide products would not
be detected in the 11 to 12% polyacrylamide gels used in these
studies.
The interaction between the upstream and downstream RNA
sequences that we have identified could involve base pair for-
mation, multiple RNA-protein contacts, or both. Smith and
FIG. 6. (A) SDS-PAGE of products of translation of pN-CDE1 (lanes 1, 3, 5,
7, and 9) and pH-CDE1 (lanes 2, 4, 6, 8, and 10) transcripts in rabbit reticulocyte
lysates containing increasing concentrations of KCl. (B) Translation of pN-CDE1
(lanes 1 and 4), pH-CDE1 (lanes 2 and 5), and pN-GA (Fig. 3A) (lanes 3 and 6)
transcripts in rabbit reticulocyte lysates containing 80 mM (lanes 1 to 3) and 150
mM (lanes 4 to 6) KCl. (C) Translation of pN-CLuc (lanes 1 and 3) and pH-CLuc
(lanes 2 and 4) transcripts in rabbit reticulocyte lysates containing 80 mM (lanes
1 and 2) and 150 mM (lanes 3 and 4) KCl. Luc, luciferase.
FIG. 7. Translation of monocistronic transcripts containing each possible
combination of the HCV-H and HCV-N 59NTRs and downstream coding se-
quences in rabbit reticulocyte lysates supplemented with increasing concentra-
tions of KCl. Products of translation were separated by SDS-PAGE and quan-
tified by PhosphorImager analysis. Relative band volumes were calculated based
on the number of methionine residues in each of the two expressed polyproteins.
pN-CDE1 (z z z ● z z z) and pH-CDE1(H) (z z z ▫ z z z), or pN-CDE1(H) (—●—) and
pH-CDE1 (—▫—), contain homologous or chimeric combinations of the 59NTRs
and polyprotein coding sequences of HCV-H and HCV-N, respectively. (A)
Quantity of translation product produced at each KCl concentration. (B) Trans-
lation efficiency of RNA transcripts relative to translation at 80 mM KCl.
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Simmonds (26) recently have proposed the existence of con-
served secondary RNA structures within the 59 167 nt of the
HCV open reading frame. This region overlaps with the seg-
ment of the coding sequence which we identified as influencing
genotype 1b translational activity. It is tempting to speculate
that these newly recognized structures form higher-ordered
interactions with the extreme 59 end of the viral RNA and that
these might function as cis-active signals in RNA replication.
The data shown in Fig. 7 indicate that the HCV-H sequence
possesses the ability to interact with either the 59NTR or down-
stream coding region of the HCV-N sequence. Despite this,
the HCV-H 59NTR is capable of robust translation of its open
reading frame, even at high KCl concentrations (Fig. 7). Thus,
if this interaction occurs within the isolated HCV-H sequence,
it appears to be far less stable than in the HCV-N sequence.
As indicated above, the 59NTRs of the genotype 1a and 1b
viruses that we studied are representative of the HCV geno-
types which comprise the majority of virus strains identified
within either the United States or Japan and which have been
suggested (although not proven) to cause infections with subtly
different natural histories (17, 23, 25, 30). Could a minimal
difference in the translational activities of these viruses at phys-
iologic ionic conditions, such as that characterized here, lead
to significant differences in replication capacity and possibly
pathogenicity? Unfortunately, it is not possible to address this
question in the absence of cell culture systems which are per-
missive for HCV infection and which mimic the replicative
environment of the hepatocyte in vivo. Nonetheless, the fact
that the AG dinucleotide sequence had similar effects on HCV
translation both in rabbit reticulocyte lysates and in transfected
Huh-T7 cells suggests that its apparent inhibition of IRES
function is not cell type specific. The effect we observed is thus
likely to be present during infection in the liver.
It is also important to note that minimal differences in trans-
lational activity can be compounded into substantial differ-
ences in replication capacity, if translation is a rate-limiting
step in virus replication. Other work in our laboratory has
shown that mutations within the 59NTR of hepatitis A virus,
which confer only a 4- to 6-fold increase in the internal initi-
ation of translation by this picornavirus in monkey kidney cells,
result in a marked increase in the size of replication foci and a
10-fold increase in virus yields in these cells (6, 22). Thus, while
there is no direct evidence that the twofold greater transla-
tional activity of the genotype 1a 59NTR has a significant im-
pact on viral replication or pathogenesis in vivo, this possibility
cannot be excluded at present.
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